Celldex Therapeutics, Inc. (FRA:TCE2)
23.60
+1.00 (4.42%)
At close: Dec 4, 2025
Celldex Therapeutics Market Cap
Celldex Therapeutics has a market cap or net worth of €1.68 billion as of December 5, 2025. Its market cap has increased by 7.48% in one year.
Market Cap
1.68B
Enterprise Value
1.18B
Revenue
2.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€23.60
Market Cap Chart
Since March 10, 2008, Celldex Therapeutics's market cap has increased from 74.63M to 1.68B, an increase of 2,154.12%. That is a compound annual growth rate of 19.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |